-100.0%
VIVK vs GSK
+14.9%
-114.9%
-100.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -27.5% | +5.0% | -32.5% | -26.3% |
| 7D | -68.7% | +4.9% | -73.6% | -68.1% |
| 30D | -90.0% | +9.9% | -99.9% | -89.9% |
| 3M | -98.1% | +0.2% | -98.2% | -98.0% |
| 6M | -99.9% | +2.3% | -102.2% | -99.9% |
| YTD | -99.9% | +7.1% | -107.0% | -99.9% |
| 1Y | -100.0% | +13.1% | -113.1% | -100.0% |
| All | -100.0% | +14.9% | -114.9% | -100.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling